Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2002
12/12/2002WO2002098286A2 Implantation of biological pacemaker that is molecularly determined
12/12/2002WO2002098217A1 Method for targeting transcriptionally active loci
12/12/2002WO2002098208A2 Tobacco biomass utilization
12/12/2002WO2002088302A9 Method for secreting proteins by bacteria, leader sequences and vectors for carrying out said method
12/12/2002WO2002086110A3 Flavone synthase i enzymes and the use thereof
12/12/2002WO2002086072A8 Antimicrobial polypeptides and their uses
12/12/2002WO2002086058A9 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence
12/12/2002WO2002085939A8 Novel molecules of the card-related protein family and uses thereof
12/12/2002WO2002085306A3 Use of follistatin to increase muscle mass
12/12/2002WO2002083891A3 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
12/12/2002WO2002083846A3 Methods of analysis and labeling of protein-protein interactions
12/12/2002WO2002081751A3 A method of increasing endogenous leptin production
12/12/2002WO2002079440A8 Transgenic mice containing gpcr5-1 gene disruptions
12/12/2002WO2002079232A3 Reducing the immunogenicity of fusion proteins
12/12/2002WO2002077249A3 Type iii bacterial strains for use in medicine
12/12/2002WO2002077212A3 D-carbamoylase from arthrobacter crystallopoietes dsm 20117
12/12/2002WO2002076508B1 Methods for delivering nucleic acid molecules into cells and assessment thereof
12/12/2002WO2002074978A3 Nucleic acid shuffling
12/12/2002WO2002074798A3 The genome of a bifidobacterium
12/12/2002WO2002072876A3 Screening method for the selection of peptides or proteins comprising discrete dimension assays, gene mutation and application assays
12/12/2002WO2002072015A3 M cell directed vaccines
12/12/2002WO2002070552A3 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF
12/12/2002WO2002068623A3 Genes encoding proteolytic enzymes from aspargilli
12/12/2002WO2002066675A9 Methods for detecting mutations
12/12/2002WO2002064161A3 Method and compositions for immunization with the pseudomonas v antigen
12/12/2002WO2002062972A3 Hybridoma cell line g250 and its use for producing monoclonal antibodies
12/12/2002WO2002062967A3 Multipotent o-2a progenitors from the neurohypophysis
12/12/2002WO2002062843A3 Modified erythropoietin (epo) with reduced immunogenicity
12/12/2002WO2002062297A9 Methods and compositions for modulating gluconeogenesis using pgc-1
12/12/2002WO2002061113A3 Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation
12/12/2002WO2002061058A3 Regulation of human phospholipase
12/12/2002WO2002061056A3 Degp2 protease that degrades photo-damaged d1 protein and a dna sequence that codes for said protease
12/12/2002WO2002059612A3 Animal model and cell-line expressing modified chlorine channel
12/12/2002WO2002057459A3 Dna sequence of the enzyme phospholipase a1 of ciliate tetrahymena, and the use of the same
12/12/2002WO2002057412A3 Plant promoters, and methods of use
12/12/2002WO2002050106A3 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4
12/12/2002WO2002048322A3 Recombinant porcine liver esterases, their use and a method for the production thereof
12/12/2002WO2002046404A3 Schizophrenia-related voltage-gated ion channel gene and protein
12/12/2002WO2002046232A3 Multimeric single-chain antibody with multiple antigen binding
12/12/2002WO2002038599A3 A plant development regulating gene and its uses
12/12/2002WO2002038188A3 Use of the human lrp/mvp promotor for a vector that can be induced by therapy
12/12/2002WO2002036774A3 Derivatives of the human macrophage-migration inhibition factor (mif) and use thereof in pharmaceutical preparations in screening methods or the identification of analogues, agonists and antagonists
12/12/2002WO2002034891A3 Immortalized preosteoblasts and method for their production
12/12/2002WO2002033090A3 Pharmaceutical preparations and methods for inhibiting tumors
12/12/2002WO2002030958A3 Casein peptide fragments with growth-influencing activity on cell cultures
12/12/2002WO2002029044A3 Modulation of the transcription of pro-inflammatory gene products
12/12/2002WO2002029040A3 25219, a novel human aminotransferase and uses therefor
12/12/2002WO2002028893A3 Plant cyclin-dependent kinase inhibitors
12/12/2002WO2002026957A3 Regulation of a human serine protease
12/12/2002WO2002026784A3 Matrix proteins m1 and m2 of infections salmon anaemia virus
12/12/2002WO2002024899A3 Improved system for regulation of transgene expression
12/12/2002WO2002024749A3 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
12/12/2002WO2002018593A3 Modulation of fas and fasl expression
12/12/2002WO2002018557A3 Human kinases
12/12/2002WO2002016565A3 Nucleotide sequences of a new class of diverged delta-9 stearoyl-acp desaturase genes
12/12/2002WO2002008292A3 Human monoclonal antibody against hepatitis c virus e2 glycoprotein
12/12/2002WO2002004622A3 Transgenic mice containing cx2 gene disruptions
12/12/2002WO2002002775A3 Calpain protease 12
12/12/2002WO2002000857A9 53320, a human acyltransferase and uses therefor
12/12/2002WO2001098779A3 Methods of identifying gabab receptor subtype-specific agonists
12/12/2002WO2001097850A3 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii)
12/12/2002WO2001097607A3 Transgenic animal model of neurodegenerative disorders
12/12/2002WO2001093983A9 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/12/2002WO2001092298A3 MUTEINS OF A CHAIN OF A PROTEIN FROM THE SUPERFAMILY OF GROWTH FACTOR TGF-$g(b)
12/12/2002WO2001089568A9 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
12/12/2002WO2001084921A9 Transgenic animal
12/12/2002WO2001038360A9 Novel hcv non-structural polypeptide
12/12/2002WO2001027303A9 Adeno-associated virus vectors encoding factor viii and methods of using the same
12/12/2002WO2001023619A9 Compounds displayed on replicable genetic packages and methods of using same
12/12/2002WO2001018207A9 Human 7tm proteins receptors and polynucleotides encoding the same
12/12/2002WO2001012816A9 Porcine endovirus gag and env and diagnostic uses thereof
12/12/2002WO2000032152A3 Compositions and methods for regulating bacterial pathogenesis
12/12/2002US20020188965 Methods of transforming plants
12/12/2002US20020188964 Transgenic turfgrasses for decoration or signaling stress conditions
12/12/2002US20020188962 Animal model for use in the development of therapies for osteoporosis, kidney defects, atherosclerosis and tumors
12/12/2002US20020188961 Non human transgenic animal in which the expression of the gene coding for insulin is deleted
12/12/2002US20020188111 For photodynamic therapy of a lesion; medical diagnosis; drug screening; bioavailability
12/12/2002US20020188109 Expression vector for use transformation of yeast cells
12/12/2002US20020188107 Plant protein for use in the treatment of cancer
12/12/2002US20020188105 Gain of function mutations in ATP-dependent transposition proteins
12/12/2002US20020188101 Conjugated peptide nucleic acids having enhanced cellular uptake
12/12/2002US20020188023 Compound
12/12/2002US20020187992 Prodrugs via acylation with cinnamate
12/12/2002US20020187972 Methods for modulating expression of exogenous genes in mammalian systems
12/12/2002US20020187954 Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to modulate cell growth
12/12/2002US20020187953 Estrogen receptor-related receptor alpha (ERRalpha) and cartilage formation
12/12/2002US20020187952 Rolling circle replicon expression vectors
12/12/2002US20020187951 Lentiviral-mediated growth factor gene therapy for neurodegenerative diseases
12/12/2002US20020187948 Implantation of biological pacemaker that is molecularly determined
12/12/2002US20020187947 Inflammation-related gene
12/12/2002US20020187946 Mammalian iap gene family, primers, probes and detection methods
12/12/2002US20020187936 Methods of treating liver disease and liver damage with growth hormone and foxM1B
12/12/2002US20020187930 Substances and their uses
12/12/2002US20020187924 Adjusting Rna translation
12/12/2002US20020187921 Transgenic zebrafish models for neurodegenerative disease
12/12/2002US20020187553 Packaging systems for human recombinant adenovirus to be used in gene therapy
12/12/2002US20020187544 Uropathogenic E. coli D-serine detoxification operon
12/12/2002US20020187543 Enhanced dispersion of adenoviral vectors by fusogenic membrane glycoproteins
12/12/2002US20020187542 Fatty-acid amide hydrolase
12/12/2002US20020187539 Nucleotide sequences coding polypeptide for use in flavonoid biosynthesis in plants
1 ... 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 2655 2656 2657 2658 2659 ... 4023